1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Cardiovascular disease: risk assessment and reduction, including lipid modification

Clinical guideline [CG181] Published date: 18 July 2014 Last updated: 27 September 2016

Uptake of this guidance
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Surveillance report  
  • Surveillance report 2018 – Cardiovascular disease: risk assessment and reduction, including lipid modification (2014) NICE guideline CG181  
  • Appendix A: Evidence summaries PDF 1.14 MB 25 January 2018  
  • Appendix B: Stakeholders comments PDF 1 MB 25 January 2018  
  • Full guidance  
  • Lipid modification (update): full guideline PDF 7.53 MB 27 September 2016  
  • Lipid modification (update): appendices PDF 9.31 MB 27 September 2016